Patent details

Basic Information

Publication number:

EP1549344

PCT Application Number:

PCT/EP/2003/011164

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037579315

PCT Publication Number:

WO/2004/032960

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS DIRECTED TO ERB-B1 RECEPTORS

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES RELATIVES A DES RECEPTEURS DE ERB-B1

German Title of Invention:

PHARMAZEUTUSCHE ZUSAMMENSETUNGEN GEGEN DEN ERB-B1 REZEPTOR

SPC Number:

Dates

Filing date:

09/10/2003

Grant date:

07/01/2015

EP Publication Date:

07/01/2015

PCT Publication Date:

22/04/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/07/2005

EP B1 Publication Date:

07/01/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/10/2016

Expiration date:

09/10/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/10/2003

 

 

Name:

Merck Patent GmbH

Address:

Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)

Inventor

1

Name:

KREYSCH Hans-Georg

Address:

Germany (DE)

2

Name:

SCHMIDT Jürgen

Address:

Germany (DE)

Priority

1

Priority Number:

02022389

Priority Date:

10/10/2002

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

02022390

Priority Date:

10/10/2002

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 39/395;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

29/09/2015

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages